Terms: = Colorectal cancer AND RPL22, EAP, 6146
14 results:
1. The Management of Direct Oral Anticoagulants for colorectal Endoscopic Submucosal Dissection: A Multicenter Observational Study.
Arimoto J; Ohata K; Tachikawa J; Goto S; Hayashi A; Ebisawa Y; Kobayashi M; Okada N; Kuwabara H; Nakaoka M; Sakai E; Kano Y; Minato Y; Kuriyama H; Chiba H
Dig Dis Sci; 2024 Mar; 69(3):933-939. PubMed ID: 38340260
[TBL] [Abstract] [Full Text] [Related]
2. Development and psychometric validation of the colorectal cancer Literacy Scale-Uruguay Version.
Buki LP; Reich M; Wang J; Sanabia S; Larrosa D; Sologaistoa B; Blanco M
Front Public Health; 2023; 11():1179792. PubMed ID: 37614455
[TBL] [Abstract] [Full Text] [Related]
3. Expansion of germline RPS20 mutation phenotype to include Diamond-Blackfan anemia.
Bhar S; Zhou F; Reineke LC; Morris DK; Khincha PP; Giri N; Mirabello L; Bergstrom K; Lemon LD; Williams CL; Toh Y; Elghetany MT; Lloyd RE; Alter BP; Savage SA; Bertuch AA
Hum Mutat; 2020 Nov; 41(11):1918-1930. PubMed ID: 32790018
[TBL] [Abstract] [Full Text] [Related]
4. Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine.
Dercle L; Ma J; Xie C; Chen AP; Wang D; Luk L; Revel-Mouroz P; Otal P; Peron JM; Rousseau H; Lu L; Schwartz LH; Mokrane FZ; Zhao B
Eur J Radiol; 2020 Apr; 125():108850. PubMed ID: 32070870
[TBL] [Abstract] [Full Text] [Related]
5. rpl22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance.
Rao S; Peri S; Hoffmann J; Cai KQ; Harris B; Rhodes M; Connolly DC; Testa JR; Wiest DL
PLoS One; 2019; 14(10):e0222392. PubMed ID: 31581233
[TBL] [Abstract] [Full Text] [Related]
6. Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?
Pellerin O; Pereira H; Van Ngoc Ty C; Moussa N; Del Giudice C; Pernot S; Déan C; Chatellier G; Sapoval M
Eur Radiol; 2019 Oct; 29(10):5253-5263. PubMed ID: 30937583
[TBL] [Abstract] [Full Text] [Related]
7. Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer.
Mayer RJ; Hochster HS; Cohen SJ; Winkler R; Makris L; Grothey A
Cancer Chemother Pharmacol; 2018 Dec; 82(6):961-969. PubMed ID: 30350179
[TBL] [Abstract] [Full Text] [Related]
8. The molecular landscape of synchronous colorectal cancer reveals genetic heterogeneity.
Wang X; Fang H; Cheng Y; Li L; Sun X; Fu T; Huang P; Zhang A; Feng Z; Li C; Huang X; Li G; Du P; Yang H; Fang X; Li F; Gao Q; Liu B
Carcinogenesis; 2018 May; 39(5):708-718. PubMed ID: 29546405
[TBL] [Abstract] [Full Text] [Related]
9. The Immunome of Colon cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling.
Luna Coronell JA; Sergelen K; Hofer P; Gyurján I; Brezina S; Hettegger P; Leeb G; Mach K; Gsur A; Weinhäusel A
Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):73-84. PubMed ID: 29505855
[TBL] [Abstract] [Full Text] [Related]
10. Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.
Schernthaner RE; Haroun RR; Duran R; Lee H; Sahu S; Sohn JH; Chapiro J; Zhao Y; Gorodetski B; Fleckenstein F; Smolka S; Radaelli A; van der Bom IM; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1429-37. PubMed ID: 27380872
[TBL] [Abstract] [Full Text] [Related]
11. Role of ribosomal protein mutations in tumor development (Review).
Goudarzi KM; Lindström MS
Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
[TBL] [Abstract] [Full Text] [Related]
12. High frequency of rpl22 mutations in microsatellite-unstable colorectal and endometrial tumors.
Ferreira AM; Tuominen I; van Dijk-Bos K; Sanjabi B; van der Sluis T; van der Zee AG; Hollema H; Zazula M; Sijmons RH; Aaltonen LA; Westers H; Hofstra RM
Hum Mutat; 2014 Dec; 35(12):1442-5. PubMed ID: 25196364
[TBL] [Abstract] [Full Text] [Related]
13. [Four cases of advanced adenocarcinoma showing marked response to eap (etoposide, ADM, CDDP) treatment].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Fukunaga T; Mishima S
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2383-5. PubMed ID: 8259856
[TBL] [Abstract] [Full Text] [Related]
14. Growth of only highly tumorigenic cell lines is inhibited by eap, a human placental fraction.
Klein JL; Chiodino C; Yamasaki H
Cancer Lett; 1993 Jun; 70(1-2):91-9. PubMed ID: 8330307
[TBL] [Abstract] [Full Text] [Related]
